Akamis Bio has announced encouraging initial data from its ongoing Phase Ib trial of NG-350A in combination with CRT for pMMR LARC patients.

The post Akamis Bio reports early data from NG-350A Phase Ib trial appeared first on Clinical Trials Arena.